ABSTRACT
Accurate forecasts of infections for localized regions are valuable for policy making and medical capacity planning. Existing compartmental and agent-based models [1, 7–11] for epidemiological forecasting employ static parameter choices and cannot be readily contextualized, while adaptive solutions [4, 13] focus primarily on the reproduction number. In the current work, we propose a novel model-agnostic Bayesian optimization approach [3] for learning model parameters from observed data that generalizes to multiple application-specific fidelity criteria. Empirical results demonstrate the efficacy of the proposed approach with SEIR-like compartmental models on COVID-19 case forecasting tasks. A city-level forecasting system based on this approach is being used for COVID-19 response in a few highly impacted Indian cities.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study is made possible by the generous support of the American People through the United States Agency for International Development (USAID). The work described in this article was implemented under the TRACETB Project, managed by WIAI under the terms of Cooperative Agreement Number 72038620CA00006. The contents of this manuscript are the sole responsibility of the authors and do not necessarily reflect the views of USAID or the United States Government.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
No approval or exemption was required for this research.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Permission to make digital or hard copies of all or part of this work for personal or classroom use is granted without fee provided that copies are not made or distributed for profit or commercial advantage and that copies bear this notice and the full citation on the first page. Copyrights for components of this work owned by others than ACM must be honored. Abstracting with credit is permitted. To copy otherwise, or republish, to post on servers or to redistribute to lists, requires prior specific permission and/or a fee. Request permissions from permissions{at}acm.org.
Data Availability
The data used includes Public Health England COVID-19 data, New York Times COVID-19 data and data from COVID19INDIA.
https://data.london.gov.uk/dataset/coronavirus--covid-19--cases